Cue Biopharma Shares Down 4%, Presents Data Updates From its Lead Programs
<p><a href='https://financialmodelingprep.com/financial-summary/CUE'>Cue Biopharma, Inc. (NASDAQ:CUE) </a>shares closed more than 4% lower on Tuesday. Recently, the company presented data updates from its lead programs in the CUE-100 series, CUE-101 and CUE-102, at SITC. Analysts at Berenberg Bank believe the positive data provides strong support to CUE-101 and points to the potential of the entire platform. The analysts’ confidence in the outlook of CUE-101 for the treatment of HPV+ head/neck cancer is strong. </p>
NASDAQ:CUE